EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Alpha 2

Ensembl ID : ENSBTAG00000010551
Gene Symbol: ATP1A2
6 Enzyme and pathways 5 Cross references
216 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 3

Ensembl ID : ENSBTAG00000018635
Gene Symbol: ATP1A3
6 Enzyme and pathways 5 Cross references
146 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 4

Ensembl ID : ENSBTAG00000038523
Gene Symbol: ATP1A4
6 Enzyme and pathways 5 Cross references
577 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSBTAG00000002688
Gene Symbol: ATP1B1
6 Enzyme and pathways 5 Cross references
300 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSBTAG00000013680
Gene Symbol: ATP1B2
6 Enzyme and pathways 5 Cross references
281 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSBTAG00000014140
Gene Symbol: ATP1B3
6 Enzyme and pathways 5 Cross references
311 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSBTAG00000011529
Gene Symbol: ATR
18 Enzyme and pathways 5 Cross references
219 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSBTAG00000003166
Gene Symbol: AXL
4 Enzyme and pathways 5 Cross references
210 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSBTAG00000021761
Gene Symbol: BRAF
24 Enzyme and pathways 5 Cross references
233 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSBTAG00000019302
Gene Symbol: BCL2
11 Enzyme and pathways 5 Cross references
228 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSBTAG00000006526
Gene Symbol: BCL2L1
14 Enzyme and pathways 5 Cross references
272 Possible Orthologues:

Bcl2 Like 2

Ensembl ID : ENSBTAG00000019692
Gene Symbol: BCL2L2
5 Cross references
64 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).